![Rahul Banerjee: Great work by Kotb et al. on Isatuximab in Multiple Myeloma](https://oncodaily.com/pub/uploads/2025/02/BeFunky-collage-2025-02-05T211515.363-1.jpg)
Rahul Banerjee and Rami Kobt
Feb 6, 2025, 15:59
Rahul Banerjee: Great work by Kotb et al. on Isatuximab in Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared an article Rami Kobt and colleagues authored on X:
“Nice to see in CLML – great work by our Canadian colleagues Kotb et al! After 2 cycles of isatuximab in Multiple Myeloma, move to 30-min infusions. No montelukast needed, albeit they did keep dex. 30 < 75 min, so less time toxicity for pts and more time for nurses!”
Authored: Rami Kotb et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 6, 2025, 15:59
Feb 6, 2025, 15:43
Feb 6, 2025, 15:29
Feb 6, 2025, 15:21